FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Sucromate Equine Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For use in horses (estrous mares) only. Do not use in horses intended for human consumption.
For intramuscular (IM) use only. Do not administer intravascularly. Not for use in humans. Keep this and all drugs out of reach of children.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
SucroMate™ Equine is indicated for inducing ovulation within 48 hours of treatment in cyclic estrous mares with an ovarian follicle between 30 and 40 mm in diameter.
History
There is currently no drug history available for this drug.
Other Information
SucroMate™ Equine (deslorelin acetate) is a sterile, synthetic gonadotropin-releasing hormone (GnRH) analog suspension. SucroMate™ Equine is a sustained release formulation that forms an in situ gel upon intramuscular injection. Deslorelin acetate is [(6-D-tryptophan-9-(N-ethyl-Lprolinamide)- 10-deglycinamide)] GnRH. The molecular weight is 1282.6.
SUCROMATE™ EQUINE
The deslorelin acetate structural formula is:
[(6-D-tryptophan-9-(N-ethyl-L-prolinamide)-10-deglycinamide)] GnRH
Each mL contains 1.8 mg deslorelin acetate (1.7 mg deslorelin) for injection as a sterile suspension in sucrose acetate isobutyrate/propylene carbonate (70:30 wt:wt). Ten doses per vial.
Sources
Sucromate Equine Manufacturers
-
Thorn Bioscience
Sucromate Equine | Thorn Bioscience
Shake well before use. Administer 1 mL (one dose) per estrus cycle, 48 hours prior to desired ovulation. Verify that the mare is in estrus and has at least one ovarian follicle between 30 and 40 mm in diameter.
SucroMate™ Equine is a suspension of deslorelin and settling will occur over time. Warm the product for 2 minutes by rolling the vial between the palms (to reach room temperature), or allow the vial to sit for 30 minutes at room temperature prior to administration. Shake the vial vigorously for 1 minute before use. Administer a 1 mL intramuscular injection into the thick musculature of the neck.
Prior to administration, it should be determined by rectal palpation and/or ultrasonography that the cyclic estrous mare has an ovarian follicle between 30 and 40 mm in diameter. Effectiveness is contingent upon accurate diagnosis of estrus and detection of a developing follicle between 30 and 40 mm in diameter. Only 1 mL should be administered per mare during a given estrus.
Login To Your Free Account